Simfibrate: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
{{drugbox
{{drugbox
| IUPAC_name        = 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate
| IUPAC_name        = 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate
Line 25: Line 24:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
{{CMG}}  
__NOTOC__
{{SI}}
{{CMG}}


{{Editor Join}}
'''Synonyms and related keywords:''' 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin


==Overview==
==Overview==
'''Synonyms and related keywords:''' 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin
'''Simfibrate''' is a [[fibrate]]. As May 20<sup>th</sup>, 2008 there is no approved drug form for human use.
'''Simfibrate''' is a [[fibrate]]. As May 20<sup>th</sup>, 2008 there is no approved drug form for human use.


==References==
{{reflist|2}}


{{Lipid modifying agents}}
{{Lipid modifying agents}}


[[Category:Drug]]
[[Category:Cardiovascular Drugs]]
[[Category:Fibrates]]
[[Category:Fibrates]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 16:47, 27 July 2014

Simfibrate
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC23H26Cl2O6
Molar mass469.354 g/mol

WikiDoc Resources for Simfibrate

Articles

Most recent articles on Simfibrate

Most cited articles on Simfibrate

Review articles on Simfibrate

Articles on Simfibrate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Simfibrate

Images of Simfibrate

Photos of Simfibrate

Podcasts & MP3s on Simfibrate

Videos on Simfibrate

Evidence Based Medicine

Cochrane Collaboration on Simfibrate

Bandolier on Simfibrate

TRIP on Simfibrate

Clinical Trials

Ongoing Trials on Simfibrate at Clinical Trials.gov

Trial results on Simfibrate

Clinical Trials on Simfibrate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Simfibrate

NICE Guidance on Simfibrate

NHS PRODIGY Guidance

FDA on Simfibrate

CDC on Simfibrate

Books

Books on Simfibrate

News

Simfibrate in the news

Be alerted to news on Simfibrate

News trends on Simfibrate

Commentary

Blogs on Simfibrate

Definitions

Definitions of Simfibrate

Patient Resources / Community

Patient resources on Simfibrate

Discussion groups on Simfibrate

Patient Handouts on Simfibrate

Directions to Hospitals Treating Simfibrate

Risk calculators and risk factors for Simfibrate

Healthcare Provider Resources

Symptoms of Simfibrate

Causes & Risk Factors for Simfibrate

Diagnostic studies for Simfibrate

Treatment of Simfibrate

Continuing Medical Education (CME)

CME Programs on Simfibrate

International

Simfibrate en Espanol

Simfibrate en Francais

Business

Simfibrate in the Marketplace

Patents on Simfibrate

Experimental / Informatics

List of terms related to Simfibrate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and related keywords: 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin

Overview

Simfibrate is a fibrate. As May 20th, 2008 there is no approved drug form for human use.

References

Template:Lipid modifying agents